Launched in 1992, the 340B program requires drug manufacturers that participate in Medicaid to provide outpatient medications at substantial discounts to providers that serve large numbers of uninsured, underinsured and Medicaid patients. #drugpricing #lawmakers #capitolnewsillinois
Expanding a program that allows profits to grow without transparency while also delivering minimal benefit to patients at the point-of-sale risks worsening those challenges rather than solving them. #drug #oped